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Abstract 21 
The fate of anthropogenic trace organic contaminants in surface waters can be complex due 22 
to the presence of multiple parallel and consecutive transformation processes. In this 23 
study, the removal of five antiviral drugs (i.e., abacavir, acyclovir, emtricitabine, lamivudine 24 
and zidovudine) via both bio- and photo-transformation processes was investigated in 25 
laboratory microcosm experiments simulating an open-water unit process wetland 26 
receiving municipal wastewater effluent. The relative importance of the two 27 
transformation processes was strongly compound dependent. Phototransformation was 28 
the main removal mechanism for abacavir, zidovudine and emtricitabine with half-lives 29 
(t1/2,photo) in wetland water of 1.6 h, 7.6 h and 25 h, respectively. In contrast, removal of 30 
acyclovir and lamivudine was mainly attributable to slower microbial processes (t1/2,bio = 31 
74 h and 120 h, respectively). Identification of transformation products via high-resolution 32 
mass-spectrometry revealed that bio- and photo-transformation reactions took place at 33 
different moieties of the molecules. For abacavir and zidovudine, rapid transformation was 34 
attributable to the high reactivity of the cyclopropylamine and azido moiety, respectively. 35 
Despite substantial differences in kinetics of different antiviral drugs, biotransformation 36 
reactions mainly involved oxidation of hydroxyl groups to the corresponding carboxylic 37 
acids. Phototransformation rates of parent antiviral drugs and their biotransformation 38 
products were similar, indicating that prior exposure to microorganisms (e.g., in a 39 
wastewater treatment plant or a vegetated wetland) would not affect the rate of 40 
transformation of the part of the molecule that was susceptible to phototransformation. 41 
However, phototransformation strongly affected the rates of biotransformation of the 42 
hydroxyl groups, which in some cases resulted in greater persistence of abacavir and 43 
acyclovir phototransformation products.  44 
 45 
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Introduction 52 
The discharge of municipal wastewater effluents into surface waters can result in the 53 
presence of trace organic contaminants at concentrations that pose potential risks to 54 
aquatic ecosystems and drinking water resources. After their release, many trace organic 55 
contaminants are attenuated by biological and photochemical processes. Although these 56 
processes often occur simultaneously or sequentially in the environment, most studies 57 
have considered the occurrence of only one transformation process at a time.1-4 Thus, it is 58 
difficult to predict which transformation products are formed and whether or not 59 
transformation reactions occurring at one moiety alter the kinetics of subsequent 60 
transformation reactions. Furthermore, if partial transformation of a compound enhances 61 
the reactivity of other moieties, interaction of transformation processes could result in 62 
changes in the distribution of transformation products as well as their rates of removal. For 63 
example, carbamazepine, a compound that is particularly resistant to biotransformation is 64 
slowly transformed upon exposure to sunlight via direct photolysis and reaction with 65 
OH.5,6 This leads to the formation hydroxylated derivatives7 which are more easily 66 
biodegraded than the parent compound.8  67 
Open water unit process wetlands have been developed as a polishing treatment step for 68 
municipal wastewater effluents.9 These managed natural systems utilize sunlight to 69 
remove trace organic compounds and deactivate pathogens.10-12 In addition, 70 
microorganisms in the biomat formed at the bottom of these treatment basins reduce 71 
nitrate and contribute to aerobic biodegradation of trace organic contaminants.13,14 To 72 
assess the importance of the co-occurrence of biological and photochemical transformation 73 
reactions to reaction kinetics and product distribution, the fate of five antiviral drugs (i.e., 74 
abacavir, emtricitabine, lamivudine, zidovudine and acyclovir, see Figure 1) was studied 75 
under conditions comparable to those encountered in open-water unit process wetlands.  76 
Antiviral drugs were chosen because they are widely used for the treatment of diseases 77 
such as herpes, hepatitis and HIV, and have been detected at concentrations above 1 µg L-1 78 
in municipal wastewater effluents.15-18 No information about potential environmental 79 
effects resulting from the release of these compound into the aquatic environment is 80 
available so far. Furthermore, little is known about the effects of these compounds on 81 
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environmental viruses, a group of microorganisms that play a very important role in 82 
aquatic ecosystems.19  83 
By investigating transformation kinetics and transformation mechanisms under conditions 84 
comparable to those encountered in open-water unit process wetlands it is possible to gain 85 
insight into how simultaneously occurring bio- and photo-transformation reactions affect 86 
the overall fate of antiviral drugs in sunlit surface waters. These compounds also serve as 87 
models for other families of compounds that contain moieties that are susceptible to bio- 88 
and phototransformation. 89 
 90 
 
Figure 1. Antiviral drugs and their most likely sites of proposed photo- ( ) 
and biotransformation ( ) reactions. 
 
 91 
Materials and Methods 92 
Chemicals 93 
Analytical reference standards of antiviral drugs and stable isotope-labeled analogues used 94 
as internal standards (purity > 99%) were purchased from Toronto Research Chemicals 95 
(Ontario, Canada). All other chemicals and solvents were obtained from Fisher Scientific 96 
(Fairlawn, NJ).  97 
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Wetland water sampling conditions 99 
Phototransformation experiments were conducted in water collected from a pilot-scale 100 
open-water unit process wetland located in Discovery Bay, CA. The facility treats about 101 
10,000 gallons per day (4.4 × 10−4 m3 s−1) of nitrified wastewater effluent from an adjacent 102 
municipal wastewater treatment plant. Details about the open-water unit process wetland 103 
were described previously.10,13 Water collected from the open-water wetland typically 104 
contained 10 - 20 mg L-1 -N NO3-, 5 - 10 mg L-1-C DOC, and 60 - 80 mg L-1-C dissolved 105 
inorganic carbon (HCO3- and CO32-). Samples for laboratory irradiation experiments were 106 
collected from the mid-point of the wetland. All samples were filtered through pre-rinsed 107 
1μm (nominal pore size) glass fiber filters (Whatman) and were stored in the dark at 4°C 108 
until analysis, which occurred within 5 days. 109 
 110 
Laboratory photo- and biotransformation experiments (or: Determination of photo- and 111 
biotransformation kinetics) 112 
Irradiation experiments were performed using a collimated beam Oriel Solar Simulator 113 
(Spectra Physics, serial no. 91194) equipped with a 1000 W Xe lamp and either two 114 
successive atmospheric attenuation filters (Spectra Physics, serial no. 81088 & 81017) or 115 
one atmospheric and one UVB-filter (Spectra Physics, serial no. 81088 & 81050). Spectral 116 
irradiance was routinely measured with a spectroradiometer (RPS 380, International light) 117 
at different locations of the irradiated area to assess variability, which was always < 5%. 118 
Details on lamp irradiance energies and the spectra of different configurations are given in 119 
section 1.1 of the Supporting Information (SI). Irradiation experiments were carried out in 120 
100mL black-painted glass beakers that were placed in a water bath at constant 121 
temperature (18 ± 2°C). Initial concentrations of antivirals of approximately 0.5 µM were 122 
used for all kinetics experiments. Pseudo-first order phototransformation rate constants of 123 
antivirals and photochemical probe compounds used for the quantification of reactive 124 
intermediateswere calculated from the slopes of linear regression of the natural log of 125 
concentration versus time.  Control experiments in the dark revealed no degradation of 126 
antiviral drugs indicating that their transformation in wetland water can solely be 127 
attributed to photochemical processes.  128 
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For the elucidation of biotransformation kinetics experiments beakers were additionally 129 
supplemented with 10 mL of the biomat taken from the bottom of the pilot-scale wetland 130 
and kept in the dark (see Jasper et al, for further details).  131 
 132 
Direct and indirect phototransformation. Experiments to assess direct phototransformation 133 
of antiviral drugs were conducted in buffered ultrapure water at pH-values ranging from 6 134 
to 10 (pH 6 - 8: 5 mM phosphate buffer; pH 9 - 10: 5 mM borate buffer). Samples (1 mL) 135 
were collected at regular time intervals and stored at 4°C in the dark until analysis. 136 
Electronic absorption spectra of antiviral drugs at different pH values (see Fig. S2) were 137 
recorded with a UV-2600 UV-Vis Spectrophotometer (Shimadzu) using quartz-glass 138 
cuvettes (Hellma, Germany). Further details on determination of quantum yields using the 139 
p-nitroanisole (PNA)/pyridine(PYR) method20 and related calculations are provided in 140 
section 1.6 of the SI.  141 
Indirect phototransformation of antiviral drugs was investigated by the addition of specific 142 
quenchers to wetland water: N,N-dimethylaniline (DMA; 10 µM) was used to scavenge CO3-143 
radicals10, sorbic acid (2.5 mM) to scavenge excited triplet states of the dissolved organic 144 
matter (3DOM*)21, histidine (20 mM) to scavenge singlet oxygen (1O2)22 and isopropyl 145 
alcohol (IPA; 26 mM) to scavenge OH-radicals.23 In addition, experiments with specific 146 
photosensitizers and were conducted in ultrapure buffered water to determine reaction 147 
rate constants of antiviral drugs with individual reactive intermediates: For CO3- either 148 
NaNO3/NaHCO3 or NaNO3/duroquinone photosensititizer methods were used.24,25 The 149 
excited triplet state photosensitizers 3-methoxyacetophenone (3MAP) and anthraquinone-150 
2-sulfonate (AQ2S) served as a proxy for 3DOM*.26 Hydroxyl-radicals were generated by 151 
the irradiation of NaNO3 solutions.27 For 1O2 production Rose Bengal was used as a 152 
photosensitizer.28 To further verify the role of 1O2, some experiments were performed in 153 
D2O. Reaction rate constants were either determined by competition kinetics or by 154 
comparing reaction rates of antiviral drugs with those of established photochemical probe 155 
compounds (experimental details and calculations are provided in section 1.5 and 1.7). For 156 
all indirect phototransformation experiments, the concentration changes of photochemical 157 
probe compounds and antiviral drugs during irradiations were followed by HPLC-UV. 158 
Experimental and analytical details, including comprehensive results are provided in SI.   159 
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Given the structural similarities of antivirals with DNA bases, additional irradiation 160 
experiments were performed with adenine, 2-amino adenosine, cytosine, cytidine, guanine, 161 
thymidine and thymine (SI section 2.1.1) to obtain further information about the 162 
photoreactive moieties in the molecules and thus aid the identification of transformation 163 
products. 164 
 165 
Identification of photo- and biotransformation products. High resolution mass spectrometry 166 
(HR-MS; LTQ Orbitrap Velos, Thermo Scientific, Bremen, Germany) was used to conduct 167 
accurate MS and MS/MS analysis of transformation products of antiviral drugs. To this end, 168 
experiments at elevated concentrations (40 µM) were used. The LTQ Orbitrap Velos was 169 
coupled to a Thermo Scientific Accela liquid chromatography system (Accela pump and 170 
autosampler). HR-MS was conducted in the positive electrospray ionization (ESI) mode. To 171 
obtain structural information on the chemical structure of formed TPs, MSn fragmentation 172 
experiments were conducted using data dependent aquisition. Further information on the 173 
applied setup and data dependent acquisition parameters can be found in the SI (section 174 
1.2). Product formation of antiviral drugs in laboratory experiments was determined liquid 175 
chromatography tandem mass spectrometry (LC/MS/MS). Details on the analytical 176 
methods are provided in the SI (section 1.3).  177 
 178 
Combined bio- and photodegradation experiments. The fate of antiviral drugs in the 179 
presence of sunlight and microorganisms was investigated over a 72 h period in the 180 
laboratory. Amber glass beakers (250mL) were filled with 180 mL of wetland water and 20 181 
mL of freshly collected biomat material from the bottom of the Discovery Bay open-water 182 
unit process wetland. The experimental setup was the same as described above for 183 
photochemical experiments, but with three day/night cycles to simulate field conditions (8 184 
h of daily irradiation followed by 16 h in the darkness; 72 h total). Antiviral drugs were 185 
added individually at concentrations of 0.5 µM to ensure detection of both parent antiviral 186 
compounds and their transformation products. Samples were collected at regular time 187 
intervals and stored at 4°C in the dark prior to LC/MS/MS analysis, which occurred within 188 
24 h.  Further details about the analytical method can be found in the SI. 189 
 190 
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Results and Discussion 191 
Phototransformation in wetland water 192 
Phototransformation of the five investigated antiviral drugs in wetland water followed 193 
first-order kinetics (r2 ≥ 0.98; Figure S4-S8). In native wetland water (pH 8.9), the fastest 194 
phototransformation was observed for abacavir (kobs = 0.52 ± 0.06 h-1), zidovudine (kobs = 195 
0.09 ± 0.002 h-1) and emtricitabine (kobs = 0.03 ± 0.002 h-1) whereas the transformation of 196 
acyclovir and lamivudine were significantly slower (kobs = 0.012 ± 0.001 h-1 and 0.011 ± 197 
0.001 h-1, respectively) (Figure 2). No degradation of antiviral drugs in wetland water in 198 
the dark was observed indicating that their removal was solely attributable to 199 
photochemical processes. Photosynthetic activity leads to significant diurnal fluctuations of 200 
pH in open-surface wetlands.10 Therefore, phototransformation kinetics of antiviral drugs 201 
in wetland water were also determined at pH 6.5 and pH 10 (Figure 2).  202 
 203 
 
Figure 2. Phototransformation kinetics of antiviral drugs in experiments with wetland water at 
different pH values and contribution of direct and indirect photolysis processes by comparison 
with results obtained in ultrapure water. Data for wetland water are corrected for light-
absorption. Error bars show 95% confidence intervals.  
 204 
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Phototransformation of abacavir in wetland water increased when the pH value was 205 
adjusted to 6.5 or 10. This can be attributed to higher contribution of direct photolysis due 206 
to higher quantum yields at lower pH values (i.e. app is 4.2 – 11.4 times higher between pH 207 
6 – 8, compared to pH 9 and 10, SI Table S5) and faster indirect photolysis at higher pH 208 
values. Comparison of transformation kinetics with results obtained in ultrapure water 209 
revealed the dominance of indirect photodegradation processes at pH 8.9 and 10, whereas 210 
direct photolysis was more important at pH 6.5. The addition of sorbic acid and histidine 211 
significantly reduced phototransformation rates of abacavir in wetland water (Fig. S4), 212 
suggesting the involvement of 3DOM* and 1O2 in the photochemical fate of this compound. 213 
This was also supported by experiments with specific singlet oxygen and excited triplet 214 
state sensitizers (see below). Negligible removal of the structural analogues adenine and 2-215 
amino-adenosine further revealed that the photolability of abacavir can be attributed to the 216 
cyclopropyl-moiety (see SI section 2.1.1). 217 
Rates of phototransformation of zidovudine were not affected by changes in pH. 218 
Comparison with reaction rates in both ultrapure water and wetland water in the presence 219 
of scavengers revealed the dominance of direct photolysis (Fig. S5). Similar to abacavir, 220 
comparison with the depletion of structural analogues thymine and thymidine indicated 221 
that the azide moiety was responsible for the observed photoreactivity of zidovudine as 222 
both analogues showed no removal when exposed to light (see SI section 2.1.1). 223 
Phototransformation of acyclovir in wetland water increased with increasing pH. 224 
Comparison with results from ultrapure water revealed that removal at pH 8.9 was solely 225 
due to indirect photolysis, whereas at pH 10 direct photolysis was also relevant. 226 
Significantly reduced rates of acyclovir phototransformation in the presence of sorbic acid 227 
and histidine indicated the importance of 1O2 and 3DOM* to indirect photolysis (Fig. S6). In 228 
contrast to abacavir and zidovudine, phototransformation kinetics were similar to those 229 
observed for the structural analogue guanine (SI Fig.  S15). Thus, phototransformation of 230 
acyclovir can be attributed primarily to the guanine moiety.  231 
For lamivudine and emtricitabine, phototransformation kinetics in wetland water 232 
decreased with increasing pH. No removal of lamivudine was observed in ultrapure water 233 
indicating that its removal was entirely attributable to indirect photolysis. Higher 234 
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phototransformation rates of emtricitabine relative to lamivudine further indicated the 235 
strong influence of the fluorine atom for emtricitabine’s photolability. The presence of the 236 
fluorine substituent leads to a higher absorption at 300-320 nm and thus alters the 237 
compound’s UV absorbance at wavelengths between 300-320 nm (SI Fig. S2). Even though 238 
the absorption spectrum of emtricitabine did not change with pH, the quantum yield 239 
steadily decreases with increasing pH (Table S5). Phototransformation of lamivudine in 240 
wetland water was fully inhibited by sorbic acid, histidine and IPA but was unaltered in the 241 
presence of DMA (Fig. S7). This indicates the importance of 3DOM*, 1O2 and OH-radicals for 242 
its indirect phototransformation. For emtricitabine, phototransformation rates in wetland 243 
were only affected by IPA and sorbic acid (Fig. S8), indicating that reactions with 1O2 are 244 
less important for this compound. The high photostability of its associated DNA base 245 
cytosine and nucleotide cytidine revealed the importance of structural modifications (thiol 246 
group (both compounds) and fluorine (emtricitabine)) to the observed photodegradability.  247 
 248 
Additional experiments with individual reactive species revealed second order reaction 249 
rates with •OH at or above (abacavir, zidovudine) diffusion controlled levels ranging from 250 
5·109 – 1.1·1011 M-1s-1 (Table 1). Antiviral compounds were reactive with CO3•-, at rates 251 
between 1.2·106 – 1.2·109 M-1s-1, while only abacavir (1.2·109 M-1s-1) and acyclovir (1.2·107 252 
M-1s-1) were obviously reactive with 1O2. With the exception of abacavir, no depletion of 253 
antiviral compounds was observe in the presence of the model triplet photosensitizer 254 
3MAP but in presence of AQ2S at rates similar or higher than the reference probe 255 
compound TMP, indicating a selective reactivity with excited triplet states. In order to 256 
check the plausibility of results for indirect phototransformation and obtain further 257 
indications for the role of different reactive species, steady-state concentrations of reactive 258 
species measured in wetland water (Table S4) were multiplied with measured second-259 
order reaction rate constants of antivirals with 1O2, OH and CO3-, respectively (Table 1). 260 
Based on this estimation revealed for abacavir that at pH 8.9 approximately 60% of its 261 
indirect photodegradation in wetland water can be attributed to 1O2. For acyclovir the 262 
important role of 1O2 for photodegradation was also strengthened, although the prediction 263 
overestimates depletion rates by a factor two. For emtricitabine and lamivudine the 264 
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contribution of 1O2, OH and CO3- can be assumed negligible, emphasizing the role of 3DOM* 265 
and corroborating results of quenching experiments.   266 
 267 
Table 1. Quantum yields (pH 9) and apparent second-order reaction rate constants of indirect phototransformation of antiviral 
drugs via reaction with 1O2, •OH, •CO3- and excited triplet states (given relative to the degradation of the 3Sens* probe compound 
TMP). Quantum yields of antiviral drugs at pH 6-8 and pH 10 can be found in SI Table S5. 
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Abacavir  0.014 (±0.003) 1.2 x 10
9
 (± 18%) 1.1 x 10
11
 (± 3%) 1.2 x 10
9
 (± 4%) -
a
 4.88 13.5 
Zidovudine  0.45 (±0.15) n.d.  1.3 x 10
10
 (± 2%) 2.4 x 10
6 
(± 5%) 1.3 x 10
6 
 (± 4%) 0.62 n.d. 
Acyclovir  0.01 (±0.005) 1.2 x 10
7
 (± 25%) 5.0 x 10
9
 (± 2%) 1.2 x 10
8 
(± 2%) 6.3 x 10
7 
(± 4%) 0.08 n.d. 
Emtricitabine  0.016 (±0.005) n.d. 9.3 x 10
9
 (± 2%) 3.0 x 10
6
 (± 4%) 4.3 x 10
6 
(± 12%) 2.03 n.d. 
Lamivudine n.d. n.d. 9.2 x 10
9
 (± 1%) 1.2 x 10
6
 (± 3%) 1.7 x 10
6 
(± 3%) 1.86 n.d. 
n.d.: not detected above level of uncertainty; a not applicable due to reaction of abacavir with DQ also in the dark 268 
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Comparison of photo- vs biotransformation rates 270 
Dark experiments conducted with wetland water in the presence of biomat material 271 
indicated that biotransformation rates varied considerably among antiviral drugs. 272 
Biotransformation half-life times (t1/2,bio) ranged from 74 h for acyclovir to 500 h (21 d) for 273 
emtricitabine (Fig. 3; Fig. S13). Under typical wetland treatment conditions (i.e., hydraulic 274 
retention times of 2-3 days), significant biological attenuation of acyclovir and abacavir is 275 
expected whereas for the other antiviral drugs removal via microbial processes is unlikely 276 
to be an important removal pathway. Comparison of transformation rates of antiviral drugs 277 
in the dark to those observed in irradiated wetland water indicated that 278 
phototransformation processes were dominant for abacavir, zidovudine and emtricitabine, 279 
while for acyclovir and lamivudine biotransformation was similar or more important than 280 
photolysis during typical summertime conditions (Fig. 3).  281 
 282 
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Figure 3. Photo- and biotransformation rate constants k (h-1) and associated half-life time t1/2 (d) of 
antiviral drugs in laboratory experiments. Small bars within phototransformation columns indicate 
half-life times based on daily sunshine hours (9-15 hours). For the determination of biodegradation 
half-life times experiments were conducted in the presence of biomat in the dark. Error bars 
represent 95% confidence intervals obtained from linear regressions. 
 283 
Transformation of abacavir 284 
HRMS analysis indicated that four primary transformation products (TP318, TP288, TP284 285 
and TP246) were formed during photolysis of abacavir in wetland water (SI section 2.2; 286 
Table S7). In agreement with results obtained for the structural analogues 2-amino-287 
adenosine and adenine, fragmentation patterns of TP318, TP288 and TP246 revealed that 288 
the cyclopropylamine moiety was the main site of reaction, leaving the 2-amino-adenine 289 
(fragments: m/z 151.073, 134.046 and 109.051) and the 2-cyclopenten-1-methanyl 290 
moieties (fragments: m/z 95.353 and 79.054) unaltered.  291 
Exact mass calculations of TP318 showed addition of two oxygen atoms to the cyclopropyl 292 
moiety (Δm +31.9898 Da). Results from MS2 experiments were consistent with the scission 293 
of the cyclopropyl ring and the presence of a terminal hydroxyl group, as indicated by the 294 
cleavage of H2O and CH2O.  295 
For TP288, MS data suggested modification of the cyclopropyl moiety via loss of one carbon 296 
atom and the addition of one oxygen atom, leading to the formation of an acetamide, 297 
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whereas TP246 was formed via cleavage of the cyclopropyl ring. The chemical structure of 298 
TP246 was confirmed by comparison with a commercially available reference standard. 299 
The exact mass and fragmentation pattern of TP284 was consistent with loss of two 300 
protons from either the cyclopropylamine or the 2-amino-adenosine moiety (fragments 301 
m/z 149.069 and 189.088 instead of m/z 151.073 and 191.104 compared to abacavir and 302 
the other TPs). Considering the high photolability of the cyclopropyl moiety, these 303 
structural changes were most likely due to the formation of a cyclopropylimine.  304 
To assess the relative importance of direct and different indirect photolysis processes for 305 
formation of the observed abacavir transformation products, their formation was 306 
investigated in buffered water (direct photolysis only), wetland water (direct and indirect 307 
photolysis), and wetland water in the presence of different reactive intermediate 308 
scavengers. The results revealed that both direct and indirect photolysis of abacavir 309 
produced the same suite of TPs at similar relative concentrations, despite the fact that the 310 
disappearance of the parent compound was significantly accelerated in the presence of 311 
DOM and individual reactive intermediates (Fig. S17 & S18). Similar results were observed 312 
for irgarol, an algaecide that is structurally similar to abacavir, suggesting that the 313 
cycloproylamine moiety is the main site of reaction under all conditions.29 314 
Photodegradation experiments in buffered ultrapure water with different optical filters 315 
indicated that wavelengths below 320 nm preferentially led to cleavage of the cyclopropyl 316 
moiety (TP246), whereas wavelengths above 320 nm (UV-A & visible light) led to scission 317 
of the cyclopropyl ring followed by partial oxidation (TP318) (Fig. S19).  318 
These findings suggest that phototransformation of abacavir is initiated by a one electron 319 
oxidation of the cyclopropylamine moiety, leading to the formation of a 320 
cyclopropylaminium radical cation,30,31 followed by subsequent reactions resulting in the 321 
formation of various products. Interestingly, this phenomenon has also been utilized for 322 
the investigation of electron-hopping in DNA by modifying guanine and adenine with 323 
cyclopropyl moieties.32,33 Due to the instability of the initially formed closed ring radical 324 
cation, the modification results in rapid cyclopropyl ring-opening as well as 1,2-hydrogen 325 
migration, leading to the formation of an ionized allylamine.30,34 Scission of the ring is 326 
followed either by a complete cleavage of the cyclopropyl moiety (TP246) or reaction of the 327 
ring opened radical cation with H2O/O2.32,34 In the latter case, electron release from the 328 
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carbon centered radical followed by hydrolysis leads to the formation of a 3-329 
hydroxypropanaminium cation35 and subsequent addition of water results in the formation 330 
of the 3-hydroxypropanamide (TP318). In our system, TP288 is formed by photolytic 331 
cleavage of the hydroxymethyl group which leads to the formation of the acetamide 332 
product.35,36 TP284 was most likely formed via H-atom abstraction, resulting in the 333 
formation of a neutral cyclopropyl radical followed by an electron transfer reaction and/or 334 
hydrolysis and elimination of water even though this reaction has only been shown to be 335 
catalyzed by enzymes so far.37,38  336 
 337 
Experiments with biomat material in the dark to determine the relative importance of 338 
biotransformation reactions indicated that microbial transformation of abacavir mainly 339 
occurred via oxidation of the primary alcohol group of the 2-cyclopenten-1-340 
hydroxymethanyl side chain to produce the corresponding carboxylic acid (abacavir 341 
carboxylate, Fig. S13). This was consistent with previous experiments conducted with 342 
mixed liquor suspended solids from an activated sludge treatment plant.39 343 
 344 
When abacavir was exposed simultaneously to light and microorganisms (Fig. 4), a rapid 345 
loss of abacavir was observed during the first 8-hour light period (i.e., the initial 346 
concentration decreased by approximately 90 %). For the next 16 hours (i.e., the dark 347 
period) abacavir removal was significantly slower. When the light was turned back on, 348 
nearly all remaining abacavir disappeared. As expected, the light-induced transformation of 349 
abacavir gave rise to the four photo-TPs described above (middle panel of Fig. 4). The 350 
concentrations of these photo-TPs decreased by approximately 25% over the next 2.5 days, 351 
indicating that further transformation took place, either via photolytic or microbial 352 
processes.  353 
Additional biodegradation experiments with the four photo-TPs of abacavir revealed that 354 
biotransformation occurs at the same moiety as observed for the parent compound, leading 355 
to the corresponding carboxylates (TP246 carboxylate, TP284 carboxylate, TP288 356 
carboxylate and TP318 carboxylate; Fig. S20). Exact mass data and fragmentation patterns 357 
of bio-photo TPs determined by HRMS analysis are included in section 2.2 of the SI. 358 
Consequently, the observed decrease in concentration of photo-TPs shown in the middle 359 
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panel of Fig. 4 was mainly attributable to biotransformation, leading to a steady formation 360 
of carboxylate photo-TPs (bottom panel of Fig. 4). Faster transformation rates of abacavir 361 
photo-TPs observed during irradiation periods may have been attributable to enhanced 362 
biotransformation due to elevated oxygen concentrations or elevated pH values that 363 
occurred when the photosynthetic microorganisms in the biomat were active. Differences 364 
in biotransformation rates of TP246, TP284, TP288 and TP318, compared to abacavir (Fig. 365 
S14), indicate that alteration of chemical structure influences biotransformation kinetics, 366 
e.g. by affecting enzyme binding affinities or steric properties. Light-exposure of abacavir 367 
carboxylate formed in the dark led to its phototransformation, ultimately yielding the same 368 
photo-TPs as abacavir (bottom panel of Fig. 4). Considering that abacavir is already 369 
transformed extensively to abacavir carboxylate in activated sludge treatment,39 a rapid 370 
elimination of both compounds can be expected in open-water unit process wetlands. In 371 
contrast to biotransformation reactions, similar phototransformation kinetics were 372 
observed for abacavir and abacavir carboxylate (Fig. S12). TP246 carboxylate was 373 
identified as the main product that accumulates over time because it is not susceptible to 374 
further reactions.  375 
 17 
 
 
Figure 4. Transformation of abacavir (left, top) and resulting formation of photo-TPs (left, middle) and bio- / 
bio-photo-TPs (left, bottom)) as well as proposed transformation pathway (right) in combined in 3 day 
experiments in the presence of biomat with 8 hours of daily irradiation. In the transformation pathway, photo- 
and biotransformation reactions and structural changes in the molecules are indicated in orange and green, 
respectively. 
 376 
Transformation of acyclovir 377 
In contrast to abacavir, the transformation of acyclovir was dominated by microbial 378 
processes (Fig. 5), with biotransformation resulting in the formation of acyclovir 379 
carboxylate, which was not susceptible to further microbial transformation. These results 380 
are consistent with previous biotransformation experiments conducted with acyclovir in 381 
sewage sludge.40 382 
In the absence of biomat material, exposure of wetland water to simulated sunlight 383 
resulted in formation of two main photo-TPs (TP257 and TP223). HRMS analysis indicated 384 
that TP257 contains two additional oxygen atoms on the guanine moiety, as evidenced by 385 
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the detection of fragment m/z 184 instead of m/z 152 (Table S8; Fig. S16). Photosensitized 386 
degradation of guanine and guanosine occurs by reaction with excited triplet states, 1O2, 387 
OH or CO3-.41,42 The main product of the reaction of guanine with 1O2 has been identified 388 
as spiroiminodihydantoin.43-45 To assess the role of 1O2 in the phototransformation of 389 
acyclovir in wetland water, experiments were conducted in both H2O and D2O in the 390 
presence of the 1O2 sensitizer Rose Bengal (Fig. 5). Lifetimes of 1O2 in D2O are more than an 391 
order of magnitude higher than in H2O 38 and faster transformation of acyclovir in D2O 392 
confirmed the role of 1O2 for the indirect photolysis of acyclovir. In addition, the yield of 393 
TP257 increased in D2O. Due to its photochemical properties acyclovir is likely to undergo 394 
self-sensitation via photoexcitation and subsequent formation of 1O2 as shown for guanine 395 
and guanosine.47-49 For the second acyclovir photo-TP (TP223), HRMS analysis indicated 396 
the loss of two protons, most likely from the side chain, as evidenced by the detection of 397 
fragments m/z 152, 135 and 110, suggesting that the guanine moiety remained unchanged 398 
(Table S8). Additional information obtained from the fragmentation of the side chain was 399 
inconclusive but indicates oxidation of the terminal alcohol to the corresponding aldehyde 400 
via reaction with OH.50 401 
Results from 72h simulated sunlight experiments conducted in the presence of the biomat 402 
revealed a steady decrease of acyclovir during light and dark periods, indicating the 403 
dominance of biotransformation processes (Fig. 5b). However, biotransformation of 404 
acyclovir was significantly faster in the sunlight experiments compared to dark controls 405 
(Fig. 5a&b) suggesting that the higher oxygen concentrations and the elevated pH values 406 
that occurred when microorganisms in the biomat were undergoing photosynthesis played 407 
a role in the biotransformation processes.10 In the presence of simulated sunlight, 408 
production of the two phototransformation products (i.e., TP257 and TP224) was 409 
observed. No significant removal of TP257 was detected during dark periods, suggesting 410 
limited biotransformation via oxidation of the terminal hydroxyl-group of the side chain. 411 
Although the exact reason for this is unknown, a plausible explanation is that the structural 412 
modifications of the guanine core moiety prevented enzymatic oxidation of TP257. In 413 
contrast, concentrations of TP223 decreased in the dark. For the biotransformation 414 
product (i.e., acyclovir carboxylate), increasing concentrations were only observed during 415 
dark periods whereas its concentration decreased when exposed to sunlight. This indicates 416 
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that the compound was transformed further by photolytic processes, most likely via the 417 
same mechanisms as acyclovir. This was confirmed by additional irradiation experiments 418 
with acyclovir carboxylate in wetland water (results not shown).  419 
 420 
 
 
 
Figure 5. Transformation of acyclovir in the presence of biomat in the dark (a) in combined photo- and 
biotransformation experiments (b), as well as formation of TP257 via reaction of acyclovir with 1O2 in D2O and 
H2O using Rose Bengal as photosensitizer (c) and its proposed phototransformation pathway (d). The 
occurrence of acyclovir carboxylate at t0 in (a) and (b) is due to its emission by the WWTP that feeds the 
wetland. 
 421 
Transformation of zidovudine, lamivudine and emtricitabine 422 
MS spectra of the phototransformation products of emtricitabine, lamivudine and 423 
zidovudine indicated structural changes at different positions on the molecules (Table S9-424 
S11). For lamivudine and emtricitabine, HRMS analysis revealed oxidation of the riboside 425 
moiety (lamivudine TP245 and emtricitabine TP263), most likely via S-oxidation. This was 426 
confirmed by comparison with commercially available reference standards. Addition of 427 
H2O to the 5-fluoro-cytosine moiety was observed for emtricitabine (emtricitabine TP265). 428 
Experiments conducted with the fluorine-free analogue lamivudine illustrates the 429 
importance of fluorine substitution: the F-moiety increases the light absorbance at 430 
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wavelengths > 300 nm (Fig. S2) for emtricitabine and leads to faster photodegradation 431 
(Figure 1, Table S5). Emtricitabine TP265 was formed via hydration of the double bond of 432 
the 5-fluorocytosine moiety, yielding a hydroxyl-group at position C6. For zidovudine, 433 
observed phototransformations were mainly attributable to the photolability of the azido 434 
moiety. Formation of zidovudine TP239 can be explained by cleavage of N2, yielding a 435 
nitrene intermediate, which reacts further via intramolecular C-H insertion to an 436 
aziridine.51,52 Subsequent nucleophilic attack of the aziridine by water leads to the 437 
hydroxylation of the C atom in -position or the formation of a hydroxylamine (zidovudine 438 
TP257).51,53 Results from HRMS analysis of zidovudine TP221 were inconclusive but 439 
indicated cleavage of N2 and H2O from the furanosyl moiety.   440 
In addition, photolytic cleavage of the nitrogen-carbon bond between the DNA base 441 
moieties and the riboside analogue side chains was observed for all three compounds, 442 
resulting in formation 5-fluoro-cytosine (emtricitabine TP129), cytosine (lamivudine 443 
TP111) and thymine (zidovudine TP126). None of these TPs were detected in sunlight 444 
experiments in the presence of biomat (Fig. S21-22), indicating that they were rapidly 445 
transformed, most likely via microbial processes. For zidovudine, this was confirmed by 446 
additional biodegradation experiments with the photo-TPs (i.e., thymine, TP239, TP257), 447 
showing the rapid elimination of thymine (Fig. S22). Considering the importance of both 448 
thymine and cytosine as DNA building blocks, it is likely that they were incorporated into 449 
the microbial biomass. The fate of 5-fluorocytosine remains unclear. Similar to abacavir 450 
and acyclovir, biotransformation of emtricitabine, lamivudine and zidovudine was shown 451 
to result in the formation of carboxylated TPs via oxidation of the terminal alcohol as 452 
already observed for abacavir and acyclovir (Fig. S13). As carboxylated TPs are expected to 453 
follow the same phototransformation mechanisms as the parent compounds,, the 454 
interactions of photo- and biotransformation reactions is likely to result in the complete 455 
elimination of via mineralization and/or microbial uptake (Fig. 6). 456 
 457 
 458 
 459 
 460 
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Figure 6. Proposed photo- and biodegradation pathway of 
lamivudine (top), emtricitabine (middle) and zidovudine 
(bottom) in open-water wetland cells. Orange and green 
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arrows indicate photo- and biotransformation reactions, 
respectively.  
 461 
Environmental implications 462 
The differences between kinetics and transformation product formation in presence and 463 
absence of the biomat highlight the complexity of transformation reactions that lead to the 464 
removal of trace organic contaminants in open water unit process wetlands and other 465 
sunlit waters. Attempts to predict the environmental fate of organic contaminants in these 466 
systems require an understanding of both processes as well as their potential interactions.  467 
Identification of TPs showed that bio- and phototransformation reactions take place at 468 
different positions of the antiviral molecules. Phototransformation of biodegradation 469 
products was found to occur at the same location as in the parent compound. As a result, 470 
mechanisms and kinetics were similar to those observed for parent antiviral compounds. 471 
This is important because carboxylate biodegradation products are typically present in 472 
much higher concentrations in biological treated wastewater compared to parent 473 
compounds.32 In contrast, biodegradation kinetics of phototransformation products of 474 
antiviral drugs differed substantially from that observed for the parent compound even 475 
though the site of enzymatic oxidation did not change. This can be explained by differences 476 
in enzyme affinities and steric hindrance. For example, phototransformation of acyclovir 477 
created a transformation product (TP257) that was not susceptible to biotransformation 478 
by microorganisms that could oxidize the parent compound in the dark.  479 
Combining kinetic studies with investigations of transformation product formation 480 
provides a better understanding of mechanisms relevant for the removal of trace organic 481 
contaminants in sunlit waters. By conducting biotransformation studies in the presence 482 
and absence of light it is possible to assess interactions between transformation processes 483 
and the likelihood that complete mineralization of trace organic contaminants will occur. 484 
These data also suggest that relative ratios of antiviral compounds and their 485 
transformation products might be useful as in situ probes to assess the relative importance 486 
of microbial and photochemical transformation pathways. This study also highlights the 487 
need to consider the formation of different transformation products in sunlit and light-488 
shaded systems and the possibility of using knowledge of the reactivity of specific moieties 489 
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in chemical fate assessment. Considering the variety of formed transformation products, 490 
there is a need for appropriate risk assessment tools to assess potential adverse effects of 491 
transformation products with unknown toxicities on aquatic ecosystems. Finally, additional 492 
field studies are needed to further confirm the obtained laboratory results and to assess 493 
the suitability of the approach for the determination of the relative importance of 494 
individual transformation processes. 495 
 496 
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Additional information on sample analysis; UV spectra of antiviral drugs; determination of 498 
indirect photolysis reaction rate constants, quantum yields, steady state concentrations of 499 
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